Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $6.70 million. The enterprise value is -$2.68 million.
Important Dates
The next estimated earnings date is Tuesday, November 4, 2025, after market close.
Earnings Date | Nov 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SBFM has 4.56 million shares outstanding. The number of shares has increased by 8,992.21% in one year.
Current Share Class | 4.56M |
Shares Outstanding | 4.56M |
Shares Change (YoY) | +8,992.21% |
Shares Change (QoQ) | +66.32% |
Owned by Insiders (%) | 0.04% |
Owned by Institutions (%) | 9.81% |
Float | 4.55M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.10 |
Forward PS | 0.26 |
PB Ratio | 0.26 |
P/TBV Ratio | 0.29 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.04.
Current Ratio | 5.00 |
Quick Ratio | 2.49 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -636.96 |
Financial Efficiency
Return on equity (ROE) is -25.65% and return on invested capital (ROIC) is -13.40%.
Return on Equity (ROE) | -25.65% |
Return on Assets (ROA) | -11.08% |
Return on Invested Capital (ROIC) | -13.40% |
Return on Capital Employed (ROCE) | -20.59% |
Revenue Per Employee | $698,880 |
Profits Per Employee | -$121,281 |
Employee Count | 52 |
Asset Turnover | 1.19 |
Inventory Turnover | 2.25 |
Taxes
Income Tax | -162,847 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.70% in the last 52 weeks. The beta is 0.40, so SBFM's price volatility has been lower than the market average.
Beta (5Y) | 0.40 |
52-Week Price Change | -47.70% |
50-Day Moving Average | 1.47 |
200-Day Moving Average | 1.94 |
Relative Strength Index (RSI) | 53.64 |
Average Volume (20 Days) | 43,475 |
Short Selling Information
The latest short interest is 247,990, so 5.44% of the outstanding shares have been sold short.
Short Interest | 247,990 |
Short Previous Month | 288,269 |
Short % of Shares Out | 5.44% |
Short % of Float | 5.45% |
Short Ratio (days to cover) | 5.50 |
Income Statement
In the last 12 months, SBFM had revenue of $36.34 million and -$6.31 million in losses. Loss per share was -$2.54.
Revenue | 36.34M |
Gross Profit | 12.11M |
Operating Income | -5.43M |
Pretax Income | -3.72M |
Net Income | -6.31M |
EBITDA | -5.17M |
EBIT | -5.43M |
Loss Per Share | -$2.54 |
Full Income Statement Balance Sheet
The company has $10.31 million in cash and $929,026 in debt, giving a net cash position of $9.38 million or $2.06 per share.
Cash & Cash Equivalents | 10.31M |
Total Debt | 929,026 |
Net Cash | 9.38M |
Net Cash Per Share | $2.06 |
Equity (Book Value) | 25.68M |
Book Value Per Share | 5.63 |
Working Capital | 22.28M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$7.76 million and capital expenditures -$787,095, giving a free cash flow of -$8.54 million.
Operating Cash Flow | -7.76M |
Capital Expenditures | -787,095 |
Free Cash Flow | -8.54M |
FCF Per Share | -$1.88 |
Full Cash Flow Statement Margins
Gross margin is 33.33%, with operating and profit margins of -14.95% and -17.35%.
Gross Margin | 33.33% |
Operating Margin | -14.95% |
Pretax Margin | -17.80% |
Profit Margin | -17.35% |
EBITDA Margin | -14.21% |
EBIT Margin | -14.95% |
FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8,992.21% |
Shareholder Yield | -8,992.21% |
Earnings Yield | -94.17% |
FCF Yield | -127.55% |
Analyst Forecast
The average price target for SBFM is $15.00, which is 920.41% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $15.00 |
Price Target Difference | 920.41% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 8, 2024. It was a reverse split with a ratio of 1:20.
Last Split Date | Aug 8, 2024 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
SBFM has an Altman Z-Score of -1.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.24 |
Piotroski F-Score | 3 |